STOCK TITAN

Journey Medical Corporation (DERM) Net Income by Year

DERM

Journey Medical Corporation reported a net loss of $11.4M in fiscal year 2025. This represents an increase of 22.1% from the prior fiscal year. Over the trailing 12 months, Q3 FY2025 through Q2 FY2026, the same line adds up to a $6.1M net loss. The table below carries 6 fiscal years, from 2020 to 2025, and the quarters Journey Medical Corporation has filed alongside them.

FY2025 annual
Net Income -$11.4M
YoY +22.1%
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

DERM Net Income by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricTTMFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-K
Net Income-$6.1M-$11.4M+22.1%-$14.7M-280.8%-$3.9M+87.0%-$29.6M+32.7%-$44.0M-932.7%$5.3M

TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.

DERM Net Income by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-Q
Net Income-$312K+91.8%-$2.2M+45.2%-$1.2M-182.0%-$2.3M+3.1%-$3.8M-12.9%-$4.1M+61.0%$1.5M+171.0%-$2.4M-114.2%-$3.4M+59.8%-$10.4M-3.0%-$2.1M+79.9%$16.8M+266.6%

What net income means

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.

More Journey Medical Corporation financials

Frequently Asked Questions

What was Journey Medical Corporation's net income in fiscal year 2025?

Journey Medical Corporation reported a net loss of $11.4M in fiscal year 2025.

How fast is Journey Medical Corporation's net income growing?

Journey Medical Corporation (DERM) net income rose by 22.1% year over year, from -$14.7M to -$11.4M in fiscal year 2025.

What is Journey Medical Corporation's net income over the last twelve months?

Journey Medical Corporation (DERM) reported a $6.1M net loss over the trailing 12 months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.

Across the 6 fiscal years this page covers, Journey Medical Corporation (DERM) net income went from $5.3M in fiscal year 2020 to -$11.4M in fiscal year 2025.

Journey Medical Corporation (DERM) reported -$312K in net income in Q2 2026. This represents an increase of 91.8% from the same quarter a year earlier.

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Journey Medical Corporation (DERM) reported on that line in every period on record.